Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

THE METHODIST HOSPITALS, INC

NPI: 1467504555 · GARY, IN 46402 · General Acute Care Hospital · NPI assigned 01/17/2007

$75.57M
Total Medicaid Paid
1,415,134
Total Claims
1,114,849
Beneficiaries
260
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDOYLE, MATTHEW (PRESIDENT/CEO)
NPI Enumeration Date01/17/2007

Related Entities

Other providers sharing the same authorized official: DOYLE, MATTHEW

ProviderCityStateTotal Paid
THE METHODIST HOSPITALS, INC GARY IN $2.18M
THE METHODIST HOSPITALS, INC. MERRILLVILLE IN $2.17M
THE METHODIST HOSPITALS, INC GARY IN $1.37M
THE METHODIST HOSPITALS, INC GARY IN $420K
THE METHODIST HOSPITALS, INC GARY IN $172K
THE METHODIST HOSPITALS, INC GARY IN $93K
THE METHODIST HOSPITALS, INC GARY IN $33K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 170,065 $2.42M
2019 159,373 $6.82M
2020 151,735 $8.00M
2021 195,013 $11.19M
2022 262,287 $16.94M
2023 281,940 $18.64M
2024 194,721 $11.57M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 71,171 62,450 $10.89M
99284 Emergency department visit for the evaluation and management, high severity 44,281 37,734 $7.05M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 36,931 31,489 $6.41M
99282 Emergency department visit for the evaluation and management, low to moderate severity 44,171 40,002 $5.68M
71045 Radiologic examination, chest; single view 33,598 28,804 $4.76M
99218 12,275 5,351 $4.25M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 5,748 2,413 $3.98M
J9271 Injection, pembrolizumab, 1 mg 660 367 $2.97M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 39,163 33,698 $2.65M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 20,733 4,097 $1.99M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 22,261 19,450 $1.56M
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 22,793 19,955 $1.48M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 12,740 11,262 $1.44M
99221 3,117 1,684 $1.34M
59025 Fetal non-stress test 4,250 2,701 $1.17M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,724 2,345 $1.01M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7,467 4,376 $893K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 6,691 4,956 $855K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 34,805 28,764 $807K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 4,179 1,732 $775K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 36,793 30,229 $719K
70450 Computed tomography, head or brain; without contrast material 7,196 6,061 $709K
71046 Radiologic examination, chest; 2 views 8,608 7,495 $704K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 607 491 $676K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 5,807 5,143 $656K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 137,011 104,068 $570K
J2323 Injection, natalizumab, 1 mg 100 90 $524K
80053 Comprehensive metabolic panel 89,402 73,982 $507K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 10,164 5,706 $488K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 15,548 13,741 $419K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 15,549 13,741 $419K
J0897 Injection, denosumab, 1 mg 1,174 883 $417K
80050 General health panel 2,307 2,165 $381K
36415 Collection of venous blood by venipuncture 185,857 133,353 $354K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 6,882 4,309 $352K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 260 224 $290K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 585 497 $289K
84484 31,066 19,846 $205K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 9,223 8,214 $195K
J1756 Injection, iron sucrose, 1 mg 3,731 1,694 $189K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 420 380 $176K
99217 952 262 $160K
96367 3,076 1,225 $158K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 9,499 8,627 $156K
81025 31,554 27,490 $156K
96361 Intravenous infusion, hydration; each additional hour 11,317 9,315 $150K
96417 1,375 677 $143K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 820 659 $135K
80048 Basic metabolic panel (calcium, ionized) 28,442 22,827 $122K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,039 880 $121K
96375 Therapeutic injection; each additional sequential IV push 22,109 17,214 $121K
96415 1,276 460 $115K
80061 Lipid panel 11,579 10,539 $105K
J3111 Injection, romosozumab-aqqg, 1 mg 205 187 $105K
73562 2,157 1,444 $94K
76819 Fetal biophysical profile; without non-stress testing 1,777 1,247 $90K
77067 Screening mammography, bilateral, including computer-aided detection 590 552 $88K
80074 1,978 1,774 $78K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,616 1,303 $70K
81001 34,388 29,350 $65K
64483 170 120 $63K
83036 Hemoglobin; glycosylated (A1C) 8,709 8,024 $60K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 5,498 4,879 $60K
83735 15,375 12,955 $59K
83690 17,963 15,253 $59K
84443 Thyroid stimulating hormone (TSH) 6,275 5,594 $59K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,870 1,515 $57K
71260 Computed tomography, thorax, diagnostic; with contrast material 191 177 $57K
82607 6,472 5,893 $55K
97161 460 349 $53K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 376 316 $52K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3,843 3,081 $50K
73565 1,202 1,100 $47K
82728 6,185 5,600 $46K
82746 5,643 5,112 $46K
84466 6,314 5,675 $44K
83880 2,201 1,828 $43K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,183 1,009 $43K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1,594 1,467 $42K
99215 Prolong outpt/office vis 379 360 $41K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 67 64 $38K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,684 3,235 $38K
86703 3,200 2,927 $37K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 212 188 $35K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 905 789 $33K
93017 183 160 $33K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 44 37 $31K
43235 13 13 $30K
71047 1,142 623 $28K
45380 Colonoscopy, flexible; with biopsy, single or multiple 15 13 $28K
87086 Culture, bacterial; quantitative colony count, urine 6,504 5,548 $27K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 443 417 $27K
76830 Ultrasound, transvaginal 149 139 $26K
11045 106 38 $26K
73130 575 474 $25K
84702 3,004 2,500 $24K
83550 2,971 2,838 $24K
77063 Screening digital breast tomosynthesis, bilateral 588 551 $24K
72125 Computed tomography, cervical spine; without contrast material 126 104 $22K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 194 185 $21K
11043 44 12 $20K
73630 480 396 $20K
86704 1,929 1,732 $20K
76820 481 284 $19K
96411 364 113 $18K
86706 1,958 1,761 $18K
72100 1,060 885 $18K
87631 120 104 $15K
77336 101 43 $14K
86696 887 783 $14K
87070 2,239 1,914 $14K
86300 1,143 1,013 $13K
73110 214 170 $13K
86592 3,643 3,329 $13K
76801 75 68 $12K
73030 347 277 $12K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 283 245 $12K
82378 1,119 973 $11K
84439 1,875 1,660 $10K
86695 927 821 $10K
95885 35 33 $10K
83655 745 703 $9K
86803 747 690 $9K
86694 731 635 $9K
84703 1,553 1,326 $8K
87210 2,543 2,231 $8K
72082 116 99 $7K
80081 118 98 $7K
80069 1,821 1,532 $7K
97162 84 65 $7K
J2469 Injection, palonosetron hcl, 25 mcg 1,161 493 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 15 14 $6K
72040 130 106 $6K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 401 306 $5K
97116 1,241 415 $5K
81003 3,894 3,338 $5K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 29 27 $5K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 43 40 $4K
73610 119 105 $4K
82784 466 265 $4K
99205 Prolong outpt/office vis 49 42 $4K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 65 55 $4K
J2785 Injection, regadenoson, 0.1 mg 74 67 $3K
86003 26 22 $3K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 714 194 $3K
73523 42 38 $3K
72110 45 44 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 96 95 $3K
99281 Emergency department visit for the evaluation and management, self-limited or minor 24 24 $3K
73502 55 51 $2K
73560 68 50 $2K
J9267 Injection, paclitaxel, 1 mg 155 50 $2K
76881 13 12 $2K
83605 317 257 $2K
95910 15 14 $2K
82977 388 365 $2K
83615 536 446 $2K
83883 162 110 $2K
73564 35 30 $2K
85660 309 270 $1K
86334 133 114 $1K
83970 99 81 $1K
76821 16 12 $1K
84480 122 115 $1K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 106 92 $1K
85379 166 141 $1K
82248 230 221 $1K
84550 390 365 $1K
J9045 Injection, carboplatin, 50 mg 117 63 $1K
73140 20 15 $1K
J9190 Injection, fluorouracil, 500 mg 307 109 $1K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 76 47 $927.20
77417 32 13 $859.68
82570 265 251 $850.91
82043 250 239 $797.19
97530 Therapeutic activities, direct patient contact, each 15 minutes 168 57 $745.84
84153 52 48 $681.78
72170 25 24 $679.83
85610 475 307 $675.84
84156 264 250 $664.04
86850 126 115 $622.88
86901 377 293 $602.81
86900 378 293 $602.49
84481 66 62 $595.93
84165 128 107 $576.41
G0008 Administration of influenza virus vaccine 53 44 $510.21
J1885 Injection, ketorolac tromethamine, per 15 mg 31,597 26,143 $466.18
85730 143 118 $463.18
0202U Oncology (prostate), multianalyte, gene expression profiling 712 597 $416.78
82785 26 22 $378.58
85027 75 69 $368.79
82533 28 25 $316.07
84100 87 78 $294.05
86756 47 43 $283.32
97010 89 13 $277.30
86038 44 40 $256.61
92133 22 14 $247.77
82950 66 63 $245.89
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 583 497 $243.40
83721 113 101 $225.21
85045 119 80 $222.38
85007 76 70 $220.40
J3490 Unclassified drugs 309 263 $203.09
87110 17 15 $184.32
82962 102 88 $181.85
85652 164 133 $180.20
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,936 2,078 $170.82
87040 13 12 $144.48
82330 38 31 $122.26
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 11,798 6,101 $119.14
87081 33 27 $109.69
84436 20 14 $105.06
87340 12 12 $93.17
86140 34 26 $90.52
96368 1,397 574 $73.71
82565 34 25 $73.68
80051 18 12 $64.68
J0696 Injection, ceftriaxone sodium, per 250 mg 1,408 1,170 $61.35
84520 32 27 $60.08
82652 12 12 $46.10
J2704 Injection, propofol, 10 mg 5,088 3,970 $41.31
87176 26 15 $35.20
90661 12 12 $25.26
90653 21 16 $25.26
J2405 Injection, ondansetron hydrochloride, per 1 mg 12,675 9,660 $15.17
J2060 Injection, lorazepam, 2 mg 15 14 $12.47
J7030 Infusion, normal saline solution , 1000 cc 4,759 2,892 $4.64
J2270 Injection, morphine sulfate, up to 10 mg 1,530 1,027 $2.90
J7120 Ringers lactate infusion, up to 1000 cc 487 245 $2.53
J3010 Injection, fentanyl citrate, 0.1 mg 3,073 2,074 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 2,927 2,150 $0.00
J0690 Injection, cefazolin sodium, 500 mg 785 503 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 2,254 1,765 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 1,043 871 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 1,184 976 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 335 266 $0.00
90674 33 30 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 42 36 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 107 91 $0.00
A9270 Non-covered item or service 221 153 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 64 51 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 29 24 $0.00
88342 153 141 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 14 12 $0.00
96376 18 13 $0.00
J1790 Injection, droperidol, up to 5 mg 27 24 $0.00
90715 33 26 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 527 365 $0.00
J1644 Injection, heparin sodium, per 1000 units 84 36 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 681 509 $0.00
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 12 12 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 92 75 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 438 67 $0.00
J0640 Injection, leucovorin calcium, per 50 mg 258 87 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 23 13 $0.00
J3370 Injection, vancomycin hcl, 500 mg 25 14 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 24 14 $0.00
76942 27 25 $0.00
S0028 Injection, famotidine, 20 mg 32 28 $0.00
76937 17 12 $0.00